Summary
Overview
Work history
Education
Skills
Certification
Research Experience and Publications
Awards
Teaching Experience
Timeline
Generic
Dina Barakat

Dina Barakat

Swansea,UK

Summary

Qualifying from Assiut University in Egypt in 2011, I completed my internship over the course of a year, and immediately began my formal training in Clinical Oncology. My residency comprised of a 4-yr training period, extensively covering provision of both RT treatments and SACTs, training her extensively in terms of all standard LINAC-based radiotherapies (IGRT/IMRT, VMAT, 3D CRT), and systemic treatments (chemotherapy, immunotherapy/targeted therapies). Following this post, I took up a position as an Assistant Lecturer at Assiut University, a role split 80/20 between clinical and academic work. I worked 4 days per week as a clinical oncologist, spending 1 day per week teaching juniors and postgraduate residents, both formally and informally. I then took a 2yr post in the UK NHS, moving to Sheffield under the MTI scheme sponsored by the Royal College of Radiation Oncology, training in Breast, Lung, Melanoma, and Urological tumours for 2 years, and using RT techniques such as SABR, IMRT, VMAT, alongside many immunotherapies and targeted therapies. I passed my FRCR Part 1 exam, and then took up a 12mo locum consultant post at Swansea Bay University focused on Breast cancers, where I then took up my current position as a Specialist Doctor in Clinical Oncology, covering Breast.

As a lecturer of Clinical Oncology at the Faculty of Medicine, I am an ambitious educator eager to contribute academic background to winning university faculty with astrong drive to support student comprehension and deliver engaging lectures.

Overview

12
12
years of professional experience
5
5
years of post-secondary education
1
1
Certification
5
5

GMC registered with Licence to Practice (7673481)

Work history

Specialist Clinical Oncologist

Swansea Bay University Health Board
Swansea, Wales
01.2022 - Current

11 years of clinical experience in clinical oncology with special interest in treating Breast and Lung Cancers

Within a team of friendly and forward-thinking consultants and specialist grade team of clinical and medical oncologists who are committed to delivering highest standards of cancer
care, and alongside a large team of other clinical and non-clinical professionals, I am responsible for the delivery of specialized SACT and radiotherapy treatments for breast cancer patients across the region of South Wales, and participate in building and expanding a trials portfolio in these areas.
Practicing independently and in collaboration with MDTs.

Consultant and Lecturer of Clinical Oncology

Assiut University
01.2022 - Current

Locum Consultant Oncologist

Swansea Bay Univeristy Health Board
Swansea
11.2021 - 10.2022

Assistant Lecturer

Assiut University
09.2017 - 01.2022

Clinical Fellow

Sheffield Teaching Hospitals
Sheffield
08.2019 - 07.2021

Demonstrator

Assiut University
09.2015 - 08.2017

House Officer

Assiut University Hospital
03.2012 - 02.2013

Education

Doctor of Medicine - Clinical Oncology

Faculty of Medicine, Assiut Univeristy
Assiut
10.2017 - 10.2022

Master's Degree - Clinical Oncology

Faculty of Medicine, Assiut University
Assiut
2017

Doctor of Medicine - Clinical Oncology

Faculty of Medicine, Assiut University, Egypt
Assiut
2012

Diploma - Human Resources

2012

Bachelor Of Medicine and General Surgery - undefined

Assiut University
2011

Skills

  • Enthusiastic Caregiver
  • Excellent Communication Skills with oncology patients Gained through long years of clinical experience dealing with cancer patients and their families from variable backgrounds
  • Experienced Inpatient And Outpatient Caregiver
  • Patient/ Family Focused
  • Experienced in updated chemotherapy dosing and infusion skills
  • Experienced in updated different radiotherapy techniques
  • Dealing with SACT and radiotherapy complications
  • Palliative care experience for oncology patients
  • Ability to cope in stressful situations
  • Ability to work within a multidisciplinary team
  • Ability to communicate effectively both verbally and in writing with patients, carers, GP's, nurses and other agencies
  • Caring attitude to patients
  • Committed to continuing medical education and professional development
  • Honesty and reliability
  • Experience in oncology research and proposals
  • Computer Skills: Very good, ICDL certified

Certification

  • Breast Cancer Delineation ESTRO workshop course 2023.
  • Cardiff FRCR course, 2023
  • Treatment of Cervical Cancer by Royal College of Radiologists (RCR), 2023
  • Consultant Mentoring Workshop, on Thursday 22 June 2023, Organised by The Royal College of Radiologists, London, WC2A 3JW
  • Good practice in consent for hospital doctors, MDDUS, 2023
  • ESMO Breast Cancer Annual Congress, Berlin, 2023
  • The Royal Marsden Hospital Fellow of the Royal College of Radiologists
  • (FRCR) Part 2b revision course, 2022
  • Guy`s and St Thomas Breast Cancer Course, London, 2022
  • Anal Cancer Mangament by the Royal College of Radiologists, 2022
  • International Egyptian Oncology Summit Conference. Luxor, Egypt 2023 (Speaker and winner of Dr Rabab Gaafar best young oncologist presentation award)
  • Post-ESMO update meeting by Novartis, London, UK, November 2021
  • Oncology Professional Care By Closerstill Media, Oncology Professional Care, UK 2021
  • Advanced Cardiac Life Support Certified (ACLS), January, 2021
  • Venous Thromboembolism (VTE) Prevention e-learning. PALMS training, May 15, 2020
  • Safer use of insulin. PALMS training, Weston Park Hospital, UK, 2021
  • Mental Health Awareness. PALMS training, Weston Park Hospital, UK, 2021.
  • Safeguarding vulnerable adults, Weston Park Hospital, UK, 2021.
  • Safeguarding children and young people, Weston Park Hospital, UK, 2021.
  • Equality and diversity: General awareness, Weston Park Hospital, UK, 2021.
  • Management of patient on oxygen (prescribing, administration and monitoring), Weston Park Hospital, UK, 2021.
  • Data Security and Information Governance, Weston Park Hospital, UK, 2021.
  • Infection and prevention control, Weston Park Hospital, UK, 2021.
  • Drug Management of breathlessness. PALMS e-learning,Weston Park Hospital, UK, (August 2020).
  • Acute Oncology Course organized by Sheffield Teaching Hospitals (December 2019)
  • Acute kidney injury e-learning for medical doctors. PALMS training, Weston Park Hospital, UK, (May 2020).
  • Venous thromboembolism Day e-learning, Anticoagulation management, Weston Park Hospital, UK, (May 2020).
  • Digital dictation-DD Author E-learning (October 2019)
  • EDMS e-learning. PALMS training. (December 2019)
  • End of life care training for clinical/medical staff and AHPs e-learning. PALMS training, Weston Park Hospital, UK, April 2020.
  • Infection control induction training. August 2019.
  • Infection Prevention and Control Mandatory training level 2.
  • Medicines management update e-learning. PALMS training. (October 2019)
  • Moving and handling, Practical and Theory. Induction training. (August 2019)
  • Resuscitation level 1 induction training. (August 2019)
  • Acute oncology/CUP South Yorkshire regional teaching day. January 2021
  • Regional Yorkshire Training Day- Gynaecology and Haematology. January 2021
  • Optimising the NSCLC Stage III Pathway. Surgical vs Radical Considerations. An Astrazenica virtual meeting. 21st of January 2021
  • 8th UKBCG (UK Breast Cancer Group) Annual Meeting. Virtual in 2020 held on 20th November 2020
  • BCY5 - Breast Cancer in Young Women: Fifth ESO-ESMO International Symposium. European School of Oncology (ESO online course). October 2020
  • Attended the session Updates in lower GI cancer. Lectures held on Thursday, 8 October 2020 as part of the RCR 2020 Digital learning Programme
  • Updates in lower GI cancer contouring workshop: Rectal cancer contouring workshop and launch of new RCR rectal cancer IMRT guide held on Wednesday, 7 October 2020 as part of the RCR 2020 Digital learning Programme
  • South Yorkshire regional teaching day. Lung Study Day. September 2020
  • Clinical oncology trainee sessions: Radiotherapy plan review and image guided radiotherapy (IGRT). Part 1held on Tuesday, 6 October 2020 as part of the RCR 2020 Digital learning Programme
  • ESMO Congress Virtual Congress 2020 19 September – 21. September 2020
  • 2020 ASCO Virtual Education Program, Online Sessions, August 8-10, 2020:
  • The Evolution of Clinical Trials in Metastatic Breast Cancer: Design Features and Endpoints That Matter.
  • The Price of Success: Management of Toxicity From Targeted Therapy in Breast Cancer. ASCO Virtual Education Program Online Session. 2020
  • Avoiding the Swell: Advances in Lymphedema Prevention, Detection, and Management
  • Finding 'The One': Improving Access and Decision-Making Tools for Molecular Profiling in Breast Cancer
  • When Immunotherapy Fails in Lung Cancer, Then What?
  • Radiation for Oligometastatic Lung Cancer: Slippery Slope or New Frontier?
  • Checkpoint Blockade in Lung Cancer With Driver Mutation: Choose the Road Wisely
  • The Sun Giveth, the Immune System Taketh: Update on Nonmelanoma Skin Cancers
  • Colorectal Cancer in Young Adults: A Distinct Entity
  • Controversies in Management of Rectal Cancer
  • Cell Cycle–Related Drugs: The Attack of the Cell Cycle Inhibitors
  • Taboo Topics in AYA Cancer Care
  • Sexuality and Reproductive Health for Cancer Survivors
  • Managing Cutaneous Complications of Cancer
  • Safeguarding the Brain in Lung Cancer: Photons or Pills?
  • Optimizing Expectations in the Era of Precision Oncology: The Importance of Patient/Clinician Communication
  • Best Foot Forward: Neoadjuvant Therapy As Standard of Care in TripleNegative and HER2-Positive Breast Cancer
  • Practical Application of Emerging Brain Tumor Technologies
  • Clinical Controversy in Stage III Lung Cancer: T Cells With Beam or Knife?
  • Redefining Colorectal Cancer by Tumor Biology
  • Understanding and Overcoming Resistance to Immunotherapy
  • Cardio-Oncology: Cure Cancer, Save Hearts
  • And Now for Something Completely Different: Immunotherapy
  • Beyond Checkpoints in Melanoma
  • Introduction to Good Clinical Practice (GCP) eLearning. September 2019.
  • Breast Contouring. E-LfH Hub. 26/10/2019 Completed
  • Making the Most of e-IRMER: A Trainee Guide. E-LfH Hub. 20/06/2020
  • Ionising Radiation (Medical Exposure) Regulations (e-IRMER). E-LfH Hub. 20/06/2020
  • Research, Audit and Quality Improvement (R&A). E-LfH Hub. 26/06/2020
  • ESMO Congress Virtual Congress 2020, 19 September - 21 September 2020
  • BCY5 - Breast Cancer in Young Women: Fifth ESO-ESMO International Symposium, September 2020
  • THE DEBATE IS MOVING ON: HOW DO WE TRANSLATE CLINICAL
  • EVIDENCE INTO CLINICAL PRACTICE: HR+ HER2- locally advanced, metastatic breast cancer treatment, organized and funded by Pfizer Ltd. on Wednesday 5th February 2020 at De Vere Holborn Bars, London
  • Introduction to Good Clinical Practice (GCP) eLearning. September 2019.
  • International Annual Conference of Assiut Clinical Oncology Department, Best Of Oncology 2018. 20-22 February 2019, Sonesta Hotel, Luxor.
  • Academy on Systematic Review and Meta-analysis by Nature Research Academies, January 18th 2019
  • 11th Breast -Gynecological and Immunotherapy International Cancer Conference (BGICC), 17-18 January 2019 Fairmont Towers Hotel, Cairo, Egypt
  • Management of Hypersensitivity Reactions to Systemic Therapy completed on Dec 22, 2018 for 0.91 contact hours. Provided by: National Comprehensive Cancer Network.
  • Use of Direct Oral Anticoagulants for Treating Venous Thromboembolism in Patients with Cancer. Provided by: National Comprehensive Cancer
  • Network, completed on Dec 20, 2018 and is awarded 0.50 AMA PRA Category 1 Credit(s)™
  • MEA, Breast Cancer Leader's Summit. December 2018. Cairo. Egypt.
  • Cairo Journal Club Breast Cancer Educational Workshop: Advances in the management of breast cancer (27-28 September 2018)
  • How to write a research protocol, Quality Assurance
  • Hematology academy 2018 with Janssen
  • Recorded Presentation from the NCCN 2017 Congress Webinar Series™: Lung Cancer - Sequencing Therapy for Advanced Non-Small Cell Lung
  • Cancer completed on Jul 3, 2018 and is awarded 0.75 AMA PRA Category 1 Credit(s)™
  • Recorded Presentation from the 2017 NCCN Case Manager and Medical Director Program: Updates in the Management of Breast Cancer, completed on Jun 23, 2018 and is awarded 1.00 AMA PRA Category 1 Credit(s)™
  • Recorded Presentation from the NCCN 2017 Congress Webinar Series: Breast Cancer - Imaging Studies in Breast Cancer completed on Dec 19, 2017 and is awarded 0.50 AMA PRA Category 1 Credit(s)™
  • Recorded Presentation from the NCCN 2017 Congress Webinar Series: Breast Cancer - Adjuvant and Neoadjuvant Therapies, Including SABCS Updates completed on Dec 19, 2017 and is awarded 0.75 AMA PRA Category 1 Credit(s)™
  • Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Breast Cancer completed on Dec 18, 2017 and is awarded 0.75 AMA PRA Category 1 Credit(s)™
  • Metastatic Breast Cancer “from A-Z”. Optimizing the Patient Care, ( Cairo Journal Club, Conrad Hotel, Cairo, Egypt, August 2017)
  • Basic Life Support Training (American Heart Association certified, 2017)
  • 9th CAIRO Journal Club ( Intercontinental City Stars Hotel, Cairo, Egypt, April 2017
  • 8th Best Of Oncology 2017 Conference (Clinical Oncology Department,
  • Assiut University, Luxor, Egypt. Feb 2017)
  • Recorded presentation from the 2016 NCCN Oncology Case Manager and Medical Director Program: Practical Considerations in the long term management of patients with CML (Feb 2017)
  • NCCN Guidelines Update: Locoregional Treatment Approaches for HCC (Feb 2017)
  • Emerging Paradigms in the treatment of Localized Rectal Cancer (Feb 2017)
  • Archived Monthly Oncology Tumor Boards: A MDT approach to individualized patient care- CRC (Feb 2017)
  • Optimizing the treatment of Advanced Prostate Cancer: Expert Review of the latest data and guideline recommendations (Jan 2017)
  • Recorded Presentation from the NCCN 2016 Congress Webinar Series:
  • Immunotherapies in Cancer – Melanoma. Completed on Feb 28, 2017. 1.00 AMA PRA Category 1 Credit(s)™. Provided by: National Comprehensive Cancer Network
  • Recorded presentation from the NCCN 2016 Congress Webinar Series: Lung Cancer Sequencing Targeted Therapy for patients with Metastatic NSCLC (Jan 2017)
  • Recorded presentation from the NCCN 2016 Congress Webinar Series: Breast Cancer- Early stage Breast Cancer: Role of Multigene Assays & SABCS Updates on Adjuvant & Neoadjuvant Therapies (August 2016)
  • Archived Monthly Oncology Tumor Boards: A MDT Approach to
  • Individualized Patient Care- Breast Cancer – Hormone Sensitive (NCCN, Aug. 2016)
  • Best Of ASCO (Egypt), 2016 (October 2016)
  • Best Of ASTRO Egypt 2016 (October 2016)
  • Hormone Sensitive Metastatic Disease: ASCO Tumor Boards (April, 2016)
  • PIK3CA Mutation: Molecular Oncology Tumor Board, ASCO University (April, 2016)
  • Treating Hodgkin Lymphoma – Are You Up to the Challenge? Karen: A 28Year-Old Female Newly Diagnosed With Stage IIA Nodular Sclerosing Hodgkin Lymphoma (Haymarket Medical Education, Feb 2016)
  • Treating Hodgkin Lymphoma – Are You Up To the Challenge? Jake: A 22 Year-Old Male Patient with ABVD-Resistant Relapsed Classical Hodgkin Lymphoma (Haymarket Medical Education ,Feb 2016)
  • New Challenges in the Prevention and Management of Tumor Lysis Syndrome in Patients with CLL (Haymarket Medical Education, Feb 2016)
  • The Alexandria Society For Cancer Patient Care Annual Conference in Association with Alexandria Clinical Oncology Department And Saudi
  • Cancer Foundation: Targeted therapy ''Future Directions" (29th April 2015)
  • Human Health – Diet & Nutrition Course, 2012, Online ALISON courses
  • Human Health – Global Health Issues Course, 2012, Online ALISON courses
  • Diploma In Health Studies,2012, Online ALISON courses
  • Human Health – Health & Human Development Course, 2012, Online ALISON courses
  • Diploma in Human Resources, 2012, Online ALISON courses
  • Mental Health & IIness Course, 2012, Online ALISON courses

Research Experience and Publications

  • MD thesis under the title: Prognostic Value of Serum Vitamin D Levels in Egyptian Females with Breast Cancer
  • Master Thesis titled: Retrospective study of the Clinical Outcomes of estrogen receptor-negative and Progesterone receptor-positive invasive breast cancer, 2013-2016

• Low baseline vitamin D levels increase the risk   of bone metastases among females with breast cancer - Hospital based cohort   study. DOI: 10.1016/j.canep.2023.102374

• Low baseline vitamin D levels correlate with   adverse pathological features and clinical outcomes among patients with   breast cancer. Journal of Clinical Oncology 2022. DOI:   10.1200/JCO.2022.40.16_suppl.552

• Eye metastasis in breast cancer: case report   and review of the literature. February 2022. ecancermedicalscience. DOI:   10.3332/ecancer.2022.1353

• Real-world-outcomes for ALK positive advanced   NSCLC patients treated in

South Yorkshire. June   2021Lung Cancer 156:S39. DOI: 10.1016/S01695002(21)00292-0

• Early-onset colorectal cancer prognosis,   conflict resolution, review of literature and meta-analysis.

DOI:https://doi.org/10.1016/j.annonc.2020.10.116

• Clinical Outcomes of Estrogen Negative-   Progesterone Positive Invasive Breast Cancer, Retrospective Study.   (International Journal of Science and Research (IJSR) ISSN (Online):   2319-7064 Index Copernicus Value (2015): 78.96 | Impact Factor (2015): 6.391)

• Does neoadjuvant treatment in breast cancer  significantly modulate the biological markers in the surgical specimen,   review of literature and meta-analysis.

Awards

Winner of Dr Rabab Gaafar's best young oncologist presentation award (International Egyptian Oncology Summit Conference. Luxor, Egypt 2023)

Teaching Experience

Throughout my career, I have been heavily involved in educating and mentoring students at various levels in the field of clinical oncology. My journey in academia began as a demonstrator at   Assiut University, where I played a pivotal role in imparting fundamental concepts and practical skills to junior medical students. As a demonstrator,   I facilitated interactive sessions, conducted demonstrations, and provided guidance to ensure the comprehensive understanding of oncological principles   among students.

Building upon this foundational experience, I progressed to the role of an assistant lecturer,   where I assumed increased responsibilities in curriculum development, course   coordination, and student assessment. In this capacity, I not only continued   to mentor undergraduate students but also had the opportunity to engage with   postgraduate trainees, guiding them through the complexities of clinical   oncology practice. I facilitated seminars, led small group discussions, and   supervised research projects, fostering a stimulating learning environment   conducive to academic growth and professional development.

Elevating my academic   journey further, I transitioned to the position of lecturer, where I assumed   leadership roles in teaching and curriculum planning within the clinical   oncology department at Assiut University. As a lecturer, I designed and   delivered comprehensive lectures, seminars, and workshops tailored to meet   the educational needs of a diverse cohort of learners, including junior   doctors, residents, and fellows. I emphasized evidence-based practice,   critical thinking, and interdisciplinary collaboration, equipping students   with the requisite skills and knowledge to excel in the field of oncology.

In tandem with my academic   endeavors, I have remained actively engaged in clinical practice as a   clinical oncologist at Swansea Bay University Health Board (SBUH). Despite my   clinical commitments, I have consistently prioritized education and training,   actively participating in local teaching activities within the healthcare   institution. Whether through bedside teaching, case discussions, or   multidisciplinary team meetings, I have sought to instill a culture of   continuous learning and professional development among my peers and   colleagues.

Furthermore, I have had   the privilege of serving as a trainer in the Cardiff FRCR (Fellowship of the   Royal College of Radiologists) course, where I have contributed to the   education and preparation of aspiring oncologists pursuing specialization in   radiation oncology. In this capacity, I have facilitated interactive   sessions, provided mentorship, and offered insights gleaned from my clinical   experiences, thereby enriching the educational experience of trainees and   nurturing the next generation of oncology professionals.

In summary, my teaching journey has been marked   by a steadfast commitment to excellence, innovation, and student-centered   learning. From my formative years as a demonstrator to my current roles as a   clinical oncologist and educator, I have endeavored to inspire, empower, and   shape the future of oncology through education, mentorship, and scholarly   engagement.

Example of lectures presented by me:

  • Overview of the management of ER+ve breast cancer (Lectrurer at Cardiff FRCR course 2023)
  • Management of Stage 3 Lung Cancer

(Evolving Knowledge into Practice).   (Inetrnational Presentation at Internation Egyptian Oncology Summit IEOS, and   winner of Dr R Gaffar best presenation award 2022).   https://www.slideshare.net/dinabarakatsaber/management-of-stage-3-lung-cancerpptx 

  • Anal Cancer Managament (local teaching, 2022). https://www.slideshare.net/dinabarakatsaber/anal-cancer-managamentpptx
  • Radiobiology for Clinical Oncologists, Introduction (local teaching, 2022).

https://www.slideshare.net/dinabarakatsaber/radiobiology-for-clinical-oncologists-introduction

  • Katherine trial (critical review of the results and implications on clinical practice in the UK, local teaching, WPH, 2021).

 https://www.slideshare.net/dinabarakatsaber/katherine-trial

  • Clinical Radiotherapy Planning basics for beginners. (Local Teaching, 2021).

https://www.slideshare.net/dinabarakatsaber/clinical-radiotherapy-planning-basics-for-beginners

Venous thromboembolism in cancer patients (Local teaching, 2021).

https://www.slideshare.net/dinabarakatsaber/venous-thromboembolism-in-cancer-patients

  • The Evolving Nonsurgical Management of Oligometastatic Colorectal

Cancer.  (Local teaching).

https://www.slideshare.net/dinabarakatsaber/the-evolving-nonsurgical-management-of-crc

Intra-operative radiotherapy (Local Teaching).

  • Improving Response To Hormone Therapy In Breast Cancer

New Targets, New   Therapeutic options (Local Teaching)

  • Immunotherapy Challenges in Head & Neck Cancers (Local Teaching).

https://www.slideshare.net/dinabarakatsaber/immunotherapy-challenges-in-head-and-neck-cancers

  • Molecular Monitoring and Mutations in CML (Local Teaching).

Timeline

Specialist Clinical Oncologist

Swansea Bay University Health Board
01.2022 - Current

Consultant and Lecturer of Clinical Oncology

Assiut University
01.2022 - Current

Locum Consultant Oncologist

Swansea Bay Univeristy Health Board
11.2021 - 10.2022

Clinical Fellow

Sheffield Teaching Hospitals
08.2019 - 07.2021

Doctor of Medicine - Clinical Oncology

Faculty of Medicine, Assiut Univeristy
10.2017 - 10.2022

Assistant Lecturer

Assiut University
09.2017 - 01.2022

Demonstrator

Assiut University
09.2015 - 08.2017

House Officer

Assiut University Hospital
03.2012 - 02.2013

Master's Degree - Clinical Oncology

Faculty of Medicine, Assiut University

Doctor of Medicine - Clinical Oncology

Faculty of Medicine, Assiut University, Egypt

Diploma - Human Resources

Bachelor Of Medicine and General Surgery - undefined

Assiut University
Dina Barakat